Quest Diagnostics vs West Pharmaceutical Services
Quest Diagnostics (DGX), health care, and West Pharmaceutical Services (WST), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
West Pharmaceutical Services is worth $28.8B on the stock market and Quest Diagnostics $28.2B: West Pharmaceutical Services is valued at 2% more. Quest Diagnostics trades at 25.5 times earnings and West Pharmaceutical Services at 46.5; operating margins in their latest fiscal years were 14.1% and 19.0%. Over the past year Quest Diagnostics's share price has moved +41.5% and West Pharmaceutical Services's +60.6%.
Key facts
- Quest Diagnostics market value
- $28.2B
- West Pharmaceutical Services market value
- $28.8B
- Quest Diagnostics P/E
- 25.5
- West Pharmaceutical Services P/E
- 46.5
- Quest Diagnostics revenue
- $11BFY to 2025-12-31
- West Pharmaceutical Services revenue
- $3.1BFY to 2025-12-31
- Superinvestors holding both
- 0
Market values as of .
| Measure | Quest Diagnostics | West Pharmaceutical Services |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size | ||
| Market cap | $28.2Blower | $28.8Bhigher |
| Revenue | $11Bhigher | $3.1Blower |
| Earnings | $992Mhigher | $493.7Mlower |
| Employees | 60,000higher | 10,000lower |
| Total assets | $16.2Bhigher | $4.3Blower |
| Valuation | ||
| P/E | 25.5lower | 46.5higher |
| P/S | 2.6lower | 9.4higher |
| P/B | 3.7lower | 9.7higher |
| Dividend yield | 1.29%higher | 0.21%lower |
| Profitability | ||
| Operating margin | 14.1%lower | 19.0%higher |
| Balance sheet | ||
| Net assets | $7.2Bhigher | $3.2Blower |
| Total liabilities | $8.9Bhigher | $1.1Blower |
| Total debt | $5.7Bhigher | $202.8Mlower |
| Cash on hand | $420Mlower | $791.3Mhigher |
| Price change | ||
| Today | -2.23%lower | -0.88%higher |
| 1 year | +41.5%lower | +60.6%higher |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (0)
None of the tracked investors.
Quest Diagnostics only (3)
West Pharmaceutical Services only (3)
- Bill Gates0.5%
- Brandon Haley0.2%
- Ron Baron0.1%
Percentages are each holding's share of that investor's reported portfolio. Who owns DGX · Who owns WST
More on Quest Diagnostics
More on West Pharmaceutical Services
Further comparisons
Quest Diagnostics against its closest peers
West Pharmaceutical Services against its closest peers
Learn
Questions and answers
Which is bigger, Quest Diagnostics or West Pharmaceutical Services?
By market value, West Pharmaceutical Services is the larger: $28.8B against $28.2B for Quest Diagnostics. By revenue in its latest fiscal year, Quest Diagnostics is the larger: $11B against $3.1B for West Pharmaceutical Services.
Which has the higher P/E ratio?
West Pharmaceutical Services: 46.5, against 25.5 for Quest Diagnostics. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.
Which has the higher operating margin?
West Pharmaceutical Services: 19.0%, against 14.1% for Quest Diagnostics. Operating margin is operating income as a share of revenue in the latest fiscal year.
Which has the higher dividend yield?
Quest Diagnostics: 1.29%, against 0.21% for West Pharmaceutical Services. Dividend yield is the last twelve months' dividends as a share of today's share price.
Which has more debt?
Quest Diagnostics: $5.7B, against $202.8M for West Pharmaceutical Services. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.
Which superinvestors own both Quest Diagnostics and West Pharmaceutical Services?
None of the tracked superinvestors holds both in their latest 13F filing. 3 hold Quest Diagnostics and 3 hold West Pharmaceutical Services.
Cite this page
Funkfolio, “Quest Diagnostics vs West Pharmaceutical Services”, data as of 18 November 2026. https://funkfolio.com/compare/dgx-vs-wst
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.